AI Summary of Scholarly Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Low-dose aspirin is recommended for preventing preeclampsia in pregnancy

Research area:medicine-clinicalclinical-methods

What the study found

The abstract states that low-dose aspirin is recommended in pregnancy for preventing preeclampsia, a hypertensive disorder of pregnancy. It also reports evidence of reduced maternal and perinatal morbidity, especially when aspirin is started before 16 weeks.

Why the authors say this matters

The authors say this matters because hypertensive disorders of pregnancy are major causes of maternal and perinatal illness and death globally. They conclude that low-dose aspirin has a role in improving pregnancy outcomes in high-risk pregnancies.

What the researchers tested

The article is a research review of aspirin history and its clinical applications in pregnancy. It summarizes low-dose aspirin use, guideline support, and reported pregnancy outcomes in conditions such as preeclampsia, intrauterine growth restriction (IUGR), antiphospholipid syndrome (APS), and systemic lupus erythematosus (SLE).

What worked and what didn't

The abstract reports that low-dose aspirin is associated with lower maternal and perinatal morbidity, particularly when started before 16 weeks. It also notes lower preterm birth rates, improved fetal growth in selected cases of IUGR, and better outcomes in women with APS and SLE when used alone or with heparin.

What to keep in mind

The abstract does not provide detailed study design, sample sizes, or specific outcome estimates. It also does not describe limitations beyond noting that the benefits apply to selected cases and high-risk pregnancies.

Key points

  • Low-dose aspirin is recommended for preventing preeclampsia in pregnancy.
  • The abstract says benefits are strongest when aspirin is started before 16 weeks.
  • Reported benefits include reduced maternal and perinatal morbidity and lower preterm birth rates.
  • Improved fetal growth is noted in selected cases of intrauterine growth restriction.
  • Major guidelines from ACOG, NICE, RCOG, WHO, and FIGO support low-dose aspirin in high-risk pregnancies.

Disclosure

Research title:
Low-dose aspirin is recommended for preventing preeclampsia in pregnancy
Authors:
Mukesh Kumar, Nitesh Kumar Gupta, Monika Kumari, Bharti Abhishake, Ravi Shah
Institutions:
All India Institute of Medical Sciences Bhopal, All India Institute of Medical Sciences Bhopal, All India Institute of Medical Sciences Raipur, All India Institute of Medical Sciences Raipur, All India Institute of Medical Sciences Rishikesh, All India Institute of Medical Sciences Rishikesh, Government Medical College, Government Medical College, Sher-i-Kashmir Institute of Medical Sciences
Publication date:
2026-02-25
OpenAlex record:
View
AI provenance: This post was generated by gpt-5.4-mini (OpenAI). The original authors did not write or review this post.